Welcome to our dedicated page for Verisk Analytics SEC filings (Ticker: VRSK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Verisk Analytics, Inc. (VRSK) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Verisk’s common stock is registered on the Nasdaq Global Select Market under the symbol VRSK, and its Form 8-K filings and other reports offer insight into material events, capital structure, and financial performance. These documents are a primary source for understanding how Verisk reports its results, manages financing arrangements, and documents significant corporate actions.
Verisk’s recent Form 8-K filings include reports of quarterly financial results, where the company furnishes press releases detailing revenue, net income, adjusted EBITDA, and segment performance for underwriting and claims within its Insurance segment. These filings also describe drivers of growth, such as forms, rules and loss cost services, extreme event solutions, anti-fraud solutions, and casualty solutions. Other 8-Ks document material definitive agreements, including term credit agreements and amended and restated revolving credit facilities, as well as the issuance of senior notes under a shelf registration statement to finance planned acquisitions.
Filings related to acquisitions and capital markets activity are particularly relevant for Verisk. For example, the company filed an 8-K describing an Agreement and Plan of Merger to acquire Exactlogix, Inc. (AccuLynx.com), and another 8-K outlining the issuance of 4.500% senior notes due 2030 and 5.125% senior notes due 2036, along with associated indentures and underwriting agreements. A later news release explains that Verisk terminated its definitive agreement to purchase AccuLynx and plans to redeem the acquisition-related notes under a special mandatory redemption provision, illustrating how these filings connect to subsequent corporate decisions.
On Stock Titan, these filings are supplemented by AI-powered summaries that highlight the key points of each document, helping users quickly understand the significance of complex agreements, financing terms, and financial disclosures. Real-time updates from EDGAR ensure that new 8-Ks and other forms appear promptly, while structured access to exhibits such as credit agreements, indentures, and merger agreements allows deeper analysis when needed. For investors, analysts, and insurance professionals researching VRSK, this page centralizes Verisk’s official SEC communications, including information on debt obligations, credit facilities, merger agreements, and periodic financial reporting.
Verisk Analytics (VRSK) reporting person Elizabeth Mann, Chief Financial Officer and director, disclosed a sale of 300 shares of Verisk common stock on 09/16/2025 at a price of $254.72 per share. After the transaction Ms. Mann beneficially owned 15,165 shares directly. The filing notes the shares were sold pursuant to a pre-established 10b5-1 trading plan entered into on December 13, 2024, and the Form 4 was signed by an attorney-in-fact on 09/16/2025. The form reports a routine, single non-derivative sale by an executive.
Verisk Analytics, Inc. (VRSK) Form 144 discloses a proposed sale of 300 shares of common stock through Merrill Lynch with an aggregate market value of $76,416, scheduled approximately for 09/16/2025 on NASDAQ. The shares were acquired on 10/01/2023 upon vesting of a restricted stock unit award granted under the issuers equity compensation plan. The filer previously sold three blocks of 300 shares each on 06/17/2025, 07/15/2025, and 08/15/2025 realizing gross proceeds of $92,670, $91,164, and $80,400, respectively. The Form 144 includes the required attestation about material nonpublic information; no additional terms, plan adoption date, or signature date are provided in the text.
Nicholas Daffan, Chief Information Officer of Verisk Analytics (VRSK), reported multiple transactions on 09/03/2025. He exercised 2,749 options with a $104 exercise price and 1,883 options with a $107.64 exercise price, each option series tied to the 2013 Equity Incentive Plan. He sold 5,420 shares at $265 per share pursuant to a 10b5-1 trading plan established on March 5, 2025. Following these transactions, his reported beneficial ownership is 54,337 shares. The filing is signed by an attorney-in-fact on his behalf.
Verisk Analytics (VRSK) Form 144 notifies proposed sale of 5,420 shares of common stock through Merrill Lynch with an aggregate market value of $1,436,300.00 and lists total shares outstanding as 139,714,971. The filing shows the securities were acquired via equity compensation: 652 shares vested 01/10/2025, 136 shares vested 01/15/2025, and 4,632 shares from a broker-assisted cashless exercise on 09/03/2025. The notice also discloses three prior sales by Nicholas Daffan in June, July, and August 2025, each of roughly 5,419–5,420 shares with gross proceeds reported. The proposed sale is scheduled for 09/03/2025.
Verisk Analytics filed an 8-K reporting the issuance of senior notes and related documents. The filing states a previously announced 364-day bridge loan commitment of up to $1.5 billion was terminated in connection with the issuance of the securities. The company filed an Underwriting Agreement dated August 7, 2025, and a Sixth Supplemental Indenture dated August 21, 2025. Forms of the securities are included: 4.500% Senior Notes due 2030 and 5.125% Senior Notes due 2036. The legal opinion and consent of Davis Polk & Wardwell LLP are filed as Exhibit 5.1, and the forms of the securities and related exhibits are incorporated by reference into the report.
Elizabeth Mann, Chief Financial Officer of Verisk Analytics (VRSK), reported a sale of common stock on 08/15/2025. The filing shows 300 shares were disposed of at a reported price of $268 per share, leaving Ms. Mann with 15,465 shares beneficially owned. The filing identifies the sale code "S" and notes the transaction was executed pursuant to a 10b5-1 trading plan established on December 13, 2024. The Form 4 was signed by an attorney-in-fact and filed on 08/18/2025. The document contains no derivative transactions or other amendments.
Verisk Analytics (VRSK) Form 144 reports a proposed sale of 1,100 shares of common stock to be executed through Merrill Lynch on 08/18/2025 on NASDAQ with an aggregate market value of $294,811.00. The shares were acquired on 11/14/2021 upon vesting of restricted stock units granted under Verisk s equity compensation plan. The filer discloses a recent sale of 1,100 shares on 08/15/2025 generating $294,800.00 and identifies the seller as Lee Shavel. The notice includes the standard representation that the seller does not possess undisclosed material adverse information.
Verisk Analytics insider sales by CEO/Director Shavel Lee reduced his holdings under a pre-established 10b5-1 plan. The Form 4 reports two separate open-market dispositions: 1,100 shares sold on 08/15/2025 at $268.00 and 1,100 shares sold on 08/18/2025 at $268.01. The filings show Mr. Lee owned 80,007 shares before the first reported sale and 78,907 shares after the second sale. The Form indicates the sales were made pursuant to a 10b5-1 trading plan established on November 25, 2024.
Verisk Analytics (VRSK) filed a Form 144 notifying the proposed sale of 1,100 shares of common stock through Merrill Lynch on NASDAQ, with an aggregate market value of $294,800 and an approximate sale date of 08/15/2025. The shares were acquired via vesting of restricted stock units on 04/01/2021 (748 shares) and 11/14/2021 (352 shares) as part of the issuer's equity compensation plan. The filing reports no securities sold in the past 3 months. Certain fields such as the filer CIK/CCC and the filer’s stated relationship to the issuer are not provided in the form content.
Form 144 notice by an insider of Verisk Analytics, Inc. (VRSK) reporting proposed sales of common stock. The filing shows 300 shares to be sold through Merrill Lynch (225 Liberty St, New York) with an aggregate market value of $80,400 and an approximate sale date of 08/15/2025 on NASDAQ. The shares were acquired on 10/01/2023 upon vesting of a restricted stock unit award granted as part of the issuer's equity compensation plan. The filer also disclosed two recent sales by the same person: 300 shares sold 06/17/2025 for $92,670 and 300 shares sold 07/15/2025 for $91,164. The notice includes the standard insider representation that the seller is not aware of undisclosed material adverse information.